Endo Pharmaceuticals (ENDP) to Buy Indevus Pharmaceuticals (IDEV) For $370 Million, 45% Premium
Tweet Send to a Friend
Endo Pharmaceuticals (Nasdaq: ENDP) and Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced that they have entered into a merger agreement under ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE